AB Soft ii manual Neuropathic Pain

28.Renzenbrink GJ, IJzerman MJ. Percutaneous neuromuscular electrical stimulation (P-NMES) for treating shoulder pain in chronic hemiplegia. Effects on shoulder pain and quality of life. Clin Rehabil 18(4): 359-365, 6/2004.

29.Sawatzky BJ, Slobogean GP, Reilly CW, Chambers CT, Hol AT. Prevalence of shoulder pain in adult- versus childhood-onset wheelchair users: a pilot study. J Rehabil Res Dev 42(3 Suppl 1): 1-8, 5/2005.

30.Sculco AD, Paup DC, Fernhall B, Sculco MJ. Effects of aerobic exercise on low back pain patients in treatment. Spine J 1(2): 95-101, 3/2001.

31.Shah RR, Haghpanah S, Elovic EP, Flanagan SR, Behnegar A, Nguyen V, Page SJ, Fang ZP, Chae J. MRI Findings in the Painful Poststroke Shoulder. Stroke 39(6): 1808-1813, 6/2008.

32.Tyler EJ, Jensen MP, Engel JM, Schwartz L. The reliability and validity of pain interference measures in persons with cerebral palsy. Arch Phys Med Rehabil 83(2): 236-239, 2/2002.

33.Wallace M, Rauck RL, Moulin D, Thipphawong J, Khanna S, Tudor IC. Once-daily OROS((R)) hydromorphone for the management of chronic nonmalignant pain: a dose- conversion and titration study. Int J Clin Pract 61(10): 1671- 1676, 10/2007.

34.Wallace M, Skowronski R, Khanna S, Tudor IC, Thipphawong J. Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127). Curr Med Res Opin 23(5): 981- 989, 5/2007.

35.Yu DT, Chae J, Walker ME, Fang ZP. Percutaneous intramuscular neuromuscular electric stimulation for the treatment of shoulder subluxation and pain in patients with chronic hemiplegia: a pilot study. Arch Phys Med Rehabil 82(1): 20-25, 1/2001.

36.Yu DT, Chae J, Walker ME, Kirsteins A, Elovic EP, Flanagan SR, Harvey RL, Zorowitz RD, Frost FS, Grill JH, Feldstein M, Fang ZP. Intramuscular neuromuscular electric stimulation for poststroke

shoulder pain: a multicenter randomized clinical trial. Arch

Phys Med Rehabil 85(5): 695-704, 5/2004.

Neuropathic Pain

1.Backonja MM, Stacey B. Neuropathic pain symptoms relative to overall pain rating. J Pain 5(9): 491-497, 11/2004.

2.Clermont-Gnamien S, Atlani S, Attal N, Le MF, Guirimand F, Brasseur L. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]. Presse Med 31(39 Pt 1): 1840-1845, 11/2002.

3.Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, Johnson G, Bauer M, Williams HM, Kaplan KM, Guess HA, Oxman MN. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 5(6): 344-356, 8/2004.

4.Erdemoglu AK, Varlibas A. Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy. Neurol India 54(2): 173-177, 6/2006.

5.Freynhagen R, Grond S, Schupfer G, Hagebeuker A, Schmelz M, Ziegler D, Von Giesen HJ, Junker U, Wagner KJ, Konrad C. Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine. International Journal of Clinical Practice 61(12): 1989- 1996, 12/2007.

6.Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS, Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptom Manage 30(4): 374-385, 10/2005.

7.Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain 7(12): 892-900, 12/2006.

8.Hardy JR, Rees EA, Gwilliam B, Ling J, Broadley K, A'hern R. A phase II study to establish the efficacy and toxicity of sodium

39 40